Strata Critical Medical (SRTA) Enterprise Value (2019 - 2026)

Strata Critical Medical (SRTA) has reported Enterprise Value for 8 consecutive years, with -$330000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Enterprise Value rose 99.62% year-over-year to -$330000.0; the TTM figure through Mar 2026 stood at -$330000.0 (up 99.62% YoY), while the FY2025 annual figure was -$61.2 million, up 44.35% from the prior year.
• Enterprise Value grew to -$330000.0 in Q1 2026 per SRTA's latest filing, from -$61.2 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$330000.0 in Q1 2026 and bottomed at -$269.1 million in Q1 2022.
• Historically, Enterprise Value has averaged -$131.9 million across 5 years, with a median of -$137.9 million in 2023.
• Annual changes were most pronounced in 2022 — Enterprise Value slumped 64732.77% — and 2026, when it soared 99.62%.
• Strata Critical Medical's Enterprise Value stood at -$153.8 million in 2022, then slipped by 8.0% to -$166.1 million in 2023, then surged by 33.77% to -$110.0 million in 2024, then surged by 44.35% to -$61.2 million in 2025, then soared by 99.46% to -$330000.0 in 2026.
• Business Quant data shows SRTA's Enterprise Value at -$330000.0 in Q1 2026, -$61.2 million in Q4 2025, and -$53.4 million in Q3 2025.